Disclosures for "Comprehensive Plasma Biomarker Profiling Identifies Inflammatory and Glial Pathways Linked to Severity in Status Epilepticus"
-
Dr. Kazazian has nothing to disclose.
-
Ms. Gray has received personal compensation in the range of $500-$4,999 for serving as a AAN 2025 Annual Meeting Abstract Co-Author and Presenter with Creyos.
-
Ms. Czink has nothing to disclose.
-
Ms. Labuda has nothing to disclose.
-
The institution of Dr. Leligdowicz has received research support from Academic Medical Organization of Southwestern Ontario. Dr. Leligdowicz has received personal compensation in the range of $0-$499 for serving as a Associate Editor with Critical Care.
-
The institution of Dr. Gofton has received research support from Government of Canada. The institution of Dr. Gofton has received research support from Canadian Institutes of Health Research. The institution of Dr. Gofton has received research support from Academic Medical Organisation of Southwestern Ontario. The institution of Dr. Gofton has received research support from Lawson Health Research Institute. Dr. Gofton has a non-compensated relationship as a Medical Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.